Skip to content

Relationship Between Vitamins and Radiologic Stage in Knee Osteoarthritis

Investigation of the Relationship Between Vitamin B12, Folic Acid and 25 OH D Levels and Radiologic Stage in Knee Osteoarthritis

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06267053
Enrollment
104
Registered
2024-02-20
Start date
2023-12-01
Completion date
2024-01-20
Last updated
2024-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Osteoarthritis

Keywords

Vitamin B12, Folate, Vitamin D, Gonarthrosis

Brief summary

The aim of this study is to investigate the relationship between folic acid, vitamin B12 and 25-OH vitamin D levels and radiographic staging in patients diagnosed with primary gonarthrosis.

Detailed description

While in the past osteoarthritis (OA) was believed to be a degenerative disease of cartilage alone, recently, many factors such as trauma, mechanical strain, inflammation, biochemical reactions, and metabolic irregularities have been shown to be involved in its etiology. Until now there have been many studies done to investigate the relationship between serum 25-OH Vitamin D (25(OH)D) levels and knee OA however the relationship between folic acid, vitamin B12 and knee OA has been rarely studied. Therefore, the aim of this study is to investigate the relationship between folic acid, vitamin B12 and 25(OH)D levels and radiographic staging in patients diagnosed with primary gonarthrosis. The files of patients who presented to Sadi Konuk Training and Research Hospital's outpatient clinic of Physical Medicine and Rehabilitation with knee pain between June and December 2023 and were diagnosed with gonarthrosis according to the American College of Rheumatology (ACR) classification criteria were retrospectively reviewed. Either one way ANOVA or Kruskal Wallis H test was used to compare means determined based on the result of the Shapiro Wilk test. Bonferroni PostHoc was used to compare between groups. The statistical analysis was performed with Statistical Package for the Social Sciences (SPSS) version 21 (New York, USA) with significance set at p \< 0.05.

Interventions

DIAGNOSTIC_TESTDirect digital radiography

All the participants had anterior posterior and lateral knee xray taken within 3 months of diagnosis

DIAGNOSTIC_TEST25-OH Vitamin D

All the participants had serum 25-OH Vitamin D levels measured from venous blood within 30 days of diagnosis

DIAGNOSTIC_TESTVitamin B12

All the participants had serum Vitamin B12 levels measured from venous blood within 30 days of diagnosis

DIAGNOSTIC_TESTFolic acid

All the participants had serum folic acid levels measured from venous blood within 30 days of diagnosis

Sponsors

Bakirkoy Dr. Sadi Konuk Research and Training Hospital
Lead SponsorOTHER_GOV

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
50 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Adults (Age: 50-80) with primary gonarthrosis * Anterior-posterior and lateral knee direct digital radiography within 3 months of diagnosis * Vitamin B12, folic acid and 25-OH Vitamin D within 1 months of diagnosis

Exclusion criteria

* History of inflammatory or rheumatologic disease * History of lower extremity surgery * Pregnancy * Active malignancy * Severe mental disability

Design outcomes

Primary

MeasureTime frameDescription
25-OH Vitamin D (25(OH)D) and Kellgren Lawrence GradeBaselineOne way ANOVA was used to determine the relationship between 25(OH)D and radiographical grade.
Vitamin B12 and Kellgren Lawrence GradeBaselineKruskal Wallis H Test was used to determine the relationship between Vitamin B12 and radiographical grade.
Folic acid and Kellgren Lawrence GradeBaselineKruskal Wallis H Test was used to determine the relationship between Folic acid and radiographical grade.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026